Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 2611 to 2620 of 2621 total matches.

Escitalopram (Lexapro) for Depression

   
The Medical Letter on Drugs and Therapeutics • Sep 30, 2002  (Issue 1140)
: www.medicalletter.org Subscriptions (U.S.) 1 year-$59; 2 years-$99; 3 years-$142 $29.50 per year for students ...
Escitalopram (Lexapro - Forest), the active S-enantiomer of racemic citalopram (Celexa - Forest), a selective serotonin reuptake inhibitor (SSRI), was recently approved by the FDA for treatment of depression. The manufacturer plans to stop promoting Celexa in favor of Lexapro; Celexa will continue to be available for patients already taking it.
Med Lett Drugs Ther. 2002 Sep 30;44(1140):83-4 |  Show IntroductionHide Introduction

Indications for an Implantable Cardioverter Defibrillator

   
The Medical Letter on Drugs and Therapeutics • Nov 25, 2002  (Issue 1144)
Web Site: www.medicalletter.org Subscriptions (U.S.) 1 year-$59; 2 years-$99; 3 years-$142. $29.50 ...
There is no longer any doubt that an implantable cardioverter defibrillator (ICD) can reliably terminate most life-threatening ventricular tachyarrhythmias. The remaining question is who should get one. Guidelines prepared by an American College of Cardiology/American Heart Association task force have recently been published (G Gregoratos et al, Circulation 2002; 106:2145).
Med Lett Drugs Ther. 2002 Nov 25;44(1144):99-100 |  Show IntroductionHide Introduction

In Brief: Tamoxifen and SSRI Interactions

   
The Medical Letter on Drugs and Therapeutics • Jun 15, 2009  (Issue 1314)
Subscriptions (US): 1 year - $98; 2 years - $167; 3 years - $235. $49.00 per year for students, interns ...
Use of a selective serotonin reuptake inhibitor (SSRI) is common in women taking tamoxifen (Nolvadex, and others) for breast cancer, both to treat depression and to decrease hot flashes. However, tamoxifen must be metabolized by CYP2D6 to become pharmacologically fully active (MJ Higgins et al. J Natl Compr Canc Netw 2009; 7:203), and the SSRIs fluoxetine (Prozac, and others) and paroxetine (Paxil, and others) are strong inhibitors of CYP2D6. Sertraline (Zoloft, and others) inhibits CYP2D6 to a lesser extent. Citalopram (Celexa, and others) and escitalopram (Lexapro), the 2 other SSRIs...
Med Lett Drugs Ther. 2009 Jun 15;51(1314):45-6 |  Show IntroductionHide Introduction

In Brief: Only The Name Remains The Same

   
The Medical Letter on Drugs and Therapeutics • Jun 28, 2010  (Issue 1341)
to: permissions@medicalletter.org Subscriptions (US): 1 year - $98; 2 years - $167; 3 years - $235. $49.00 ...
A Medical Letter subscriber was surprised to discover that a new Citracal product contained not only calcium citrate, but also calcium carbonate. Citracal Plus Bone Density Builder actually contains more calcium carbonate per tablet than calcium citrate (240 mg vs. 60 mg). Another Citracal product, Citracal Plus Heart Health, also contains more calcium carbonate than calcium citrate. Many clinicians prefer calcium citrate because it can be taken with or without food, while calcium carbonate must be taken with food for optimal absorption. Other familiar over-the-counter (OTC) names also contain...
Med Lett Drugs Ther. 2010 Jun 28;52(1341):49 |  Show IntroductionHide Introduction

Generic drugs

   
The Medical Letter on Drugs and Therapeutics • Oct 14, 2002  (Issue 1141)
Phone: 914-235-0500 Fax: 914-632-1733 Web Site: www.medicalletter.org Subscriptions (U.S.) 1 year-$59 ...
When patents expire on brand-name drugs and generic formulations become available, patients and managed care organizations may express a preference for the lower-cost generics. Are they equivalent to the brand-name product?
Med Lett Drugs Ther. 2002 Oct 14;44(1141):89-90 |  Show IntroductionHide Introduction

Methamphetamine Abuse

   
The Medical Letter on Drugs and Therapeutics • Aug 02, 2004  (Issue 1188)
to disclose any potential conflict of interest. Subscriptions (U.S.) 1 year-$63; 2 years-$107; 3 years-$151 ...
Methamphetamine, a highly addictive synthetic sympathomimetic, has again become important as a drug of abuse in the US. Its resurgence has been associated with unsafe sexual practices that have resulted in an increase in HIV transmission, particularly among men who have sex with men (SJ Semple et al, J Subst Abuse Treat 2002; 22:149; A Urbina and K Jones, Clin Infect Dis 2004; 38:890).
Med Lett Drugs Ther. 2004 Aug 2;46(1188):62-3 |  Show IntroductionHide Introduction

Alefacept (Amevive) For Treatment of Psoriasis

   
The Medical Letter on Drugs and Therapeutics • Apr 14, 2003  (Issue 1154)
: www.medicalletter.org Subscriptions (U.S.) 1 year-$59; 2 years-$99; 3 years-$142. $29.50 per year for students ...
Alefacept (a le' fa sept; Amevive - Biogen) has been approved by the FDA for parenteral treatment of adults with moderate to severe chronic plaque psoriasis.
Med Lett Drugs Ther. 2003 Apr 14;45(1154):31-2 |  Show IntroductionHide Introduction

Catheter Ablation for Atrial Fibrillation

   
The Medical Letter on Drugs and Therapeutics • Jul 19, 2004  (Issue 1187)
to disclose any potential conflict of interest. Subscriptions (U.S.) 1 year-$63; 2 years-$107; 3 years-$151 ...
Advertisements are appearing in medical journals for continuing medical education courses on catheter ablation of atrial fibrillation. Is a cure at hand for this common disorder?
Med Lett Drugs Ther. 2004 Jul 19;46(1187):59-60 |  Show IntroductionHide Introduction

Problems With Dietary Supplements

   
The Medical Letter on Drugs and Therapeutics • Sep 30, 2002  (Issue 1140)
: www.medicalletter.org Subscriptions (U.S.) 1 year-$59; 2 years-$99; 3 years-$142 $29.50 per year for students ...
Millions of people now take herbal products and other "dietary supplements." The Physicians' Desk Reference has published a PDR for Herbal Medicines listing their ingredients and indications, and the Drug Topics Red Book lists their prices.
Med Lett Drugs Ther. 2002 Sep 30;44(1140):84-6 |  Show IntroductionHide Introduction

Prevention and Treatment of Heat Injury

   
The Medical Letter on Drugs and Therapeutics • Jul 21, 2003  (Issue 1161)
Web Site: www.medicalletter.org Subscriptions (U.S.) 1 year-$59; 2 years-$99; 3 years-$142. $29.50 ...
Summer heat waves cause thousands of cases of heat-related illness in the US each year and hundreds of heat-related deaths, especially among the elderly. This review describes the contributing factors, clinical signs, and ways to prevent and treat heat injury.
Med Lett Drugs Ther. 2003 Jul 21;45(1161):58-60 |  Show IntroductionHide Introduction